Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
JC Virus Infects Neurons and Glial Cells in the Hippocampus.
Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.
Nerve conduction and electromyography studies.
Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway.
[Acid-sensing ion channels as a target for neuroprotection: acidotoxicity revisited].
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents.
Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis.
Severe drug-induced liver injury related to therapy with dimethyl fumarate.
Glial Na(+) -dependent ion transporters in pathophysiological conditions.
Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients.
Guillain-Barré syndrome.
Olfactory alterations in patients with multiple sclerosis.
Safety Study of Combination Therapy with Intramuscular Avonex and Oral CellCept in Patients with Multiple Sclerosis
MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.
Imbalance in multiple sclerosis and neuromyelitis optica: association with deep sensation disturbance.
Vitamin D as a T-cell modulator in multiple sclerosis.
Stereological and flow cytometry characterization of leukocyte subpopulations in models of transient or permanent cerebral ischemia.
Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study.
Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting.
Update on therapeutic options for multiple sclerosis.
Lymphopenia in treatment-naive relapsing multiple sclerosis.
Advanced intercross line mapping suggests that ncf1 (ean6) regulates severity in an animal model of guillain-barre syndrome.
Altering the course of disease in multiple sclerosis: many large steps forward.
Engineering three dimensional micro nerve tissue using postnatal stem cells from human dental apical papilla.
Pages
« first
‹ previous
…
691
692
693
694
695
696
697
698
699
…
next ›
last »